Insert INTO PMID_Summary(PMID,summaryText,IPAddress,dtCreated) VALUES (15019161, '** The study investigates how hormones like estrogen and prolactin influence the regulation of TGF-beta and specific MMPs involved in breast cancer progression. ** \n\n** Findings show that at normal levels, prolactin and estrogen work together to lower TGF-beta and MMP levels without increasing cancer cell growth. ** \n\n** Interestingly, while high doses of prolactin can also reduce TGF-beta and MMP expression, estrogen does not have the same effect at these growth-stimulating levels. **','18.223.170.253',now()) Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells. | LitMetric

Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells.

Cancer Lett

Biology and Chemistry/Biochemistry, Georgian Court College, 900 Lakewood Avenue, Lakewood, NJ 08701, USA.

Published: March 2004

AI Article Synopsis

  • The study investigates how hormones like estrogen and prolactin influence the regulation of TGF-beta and specific MMPs involved in breast cancer progression.
  • Findings show that at normal levels, prolactin and estrogen work together to lower TGF-beta and MMP levels without increasing cancer cell growth.
  • Interestingly, while high doses of prolactin can also reduce TGF-beta and MMP expression, estrogen does not have the same effect at these growth-stimulating levels.

Article Abstract

Hormones, estrogen and prolactin, transforming growth factor-beta (TGF-beta), and matrixmetalloproteinases (MMPs) may modulate breast cancer progression. The goal of this research was to examine the regulation of expression of TGF-beta and MMPs (MMP-1, 2, 9) by estrogen and prolactin, independently and in combination, at physiological doses, and at doses stimulating cancer cell (T47D) proliferation in vitro. Prolactin, and estrogen synergistically, and similarly, inhibited the expression of TGF-beta and MMPs at physiological concentrations without altering cell proliferation, indicating a beneficial role of the hormones. The growth stimulating concentration of prolactin, but not estrogen, also inhibited the TGF-beta and MMP expression.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2003.10.019DOI Listing

Publication Analysis

Top Keywords

estrogen prolactin
12
transforming growth
8
growth factor-beta
8
breast cancer
8
expression tgf-beta
8
tgf-beta mmps
8
prolactin estrogen
8
estrogen
5
prolactin
5
inhibition transforming
4

Similar Publications

Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?

J Clin Exp Hepatol

November 2024

Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rising due to rapid lifestyle changes. Although females may be less prone to MASLD than males, specific studies on MASLD in females should still be conducted. Previous research has shown that sex hormone levels are strongly linked to MASLD in females.

View Article and Find Full Text PDF

Impact of prolactin treatment on enhancing the cellular responses of MCF7 breast cancer cells to tamoxifen treatment.

Discov Oncol

December 2024

Department of Pharmacology, College of Medicine, Taif University, P.O. Box 11099, Taif 21944, Taif, Saudi Arabia.

Breast cancer remains one of the most challenging diseases to treat due to its heterogeneity, propensity to recur, capacity to spread to distant vital organs, and, ultimately, patient death. Estrogen receptor-positive illness comprises the most common breast cancer subtype. Preclinical progress is hampered by the scarcity of medication-naïve estrogen receptor-positive tumour models that recapitulate metastatic development and treatment resistance.

View Article and Find Full Text PDF

Relationship of adiponectin, leptin and reproductive endocrine hormones with insulin resistance in polycystic ovary syndrome patients with normal BMI.

Gynecol Endocrinol

December 2024

Department of Gynaecology and Obstetrics, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Objective: This study aimed to analyze the correlation of adiponectin (APN) and leptin (LEP), reproductive endocrine hormones with insulin resistance (IR) in polycystic ovary syndrome (PCOS) patients with normal body mass index (BMI).

Methods: Totally 160 PCOS patients were categorized into the Normal BMI (BMI: 18.5-25 kg/m,  = 62) and High BMI (BMI > 25 kg/m,  = 98) groups.

View Article and Find Full Text PDF

The embryonic diapause of the giant panda (Ailuropoda melanoleuca) has caused great difficulties in monitoring pregnancy in this vulnerable species. The secretion of prolactin (PRL) from anterior pituitary glandular lactotropic cells is an important signal for the termination of embryonic dormancy. Currently, the mechanism by which PRL affects embryonic diapause in giant pandas and methods for detecting PRL in this species are poorly understood.

View Article and Find Full Text PDF

Soybean isoflavone (SIF) in soybeans are natural phytoestrogens, which is functioned as an estrogen agonistic or antagonistic. SIF regulates the capacity of animals to synthesize triacylglycerols by directly utilizing long-chain fatty acids. However, few studies have focused on its regulatory lipid metabolism in lactating dairy goats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!